Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

SABCS 2020: High-risk, HR , HER2-, early-stage BC patients continue to benefit from abemaciclib

SABCS 2020: High-risk, HR , HER2-, early-stage BC patients continue to benefit from abemaciclib

SABCS 2020: CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients

SABCS 2020: CTC dynamics may predict treatment response/prognosis in metastatic breast cancer patients

Researchers create framework to help determine timing of cancer mutations

Researchers create framework to help determine timing of cancer mutations

A library of mice to look up the best liver cancer treatment

A library of mice to look up the best liver cancer treatment

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

Researchers create framework to help determine timing of cancer mutations

Researchers create framework to help determine timing of cancer mutations

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued survival benefit

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued...

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

More from ecancer